# PeptideScanner evidence objects: Avexitide

Every published version of the records placed with Avexitide, one section per evidence object. The section anchor is the object's path id; the JSON twin is https://peptidescanner.com/evidence/v1/peptides/avexitide.json. Selected public evidence only; not medical advice.

- Objects: 3
- Manifest: https://peptidescanner.com/evidence/v1/manifest.json

---

<a id="clinicaltrials-gov-nct03373435-avexitide-v1"></a>

## ClinicalTrials.gov record NCT03373435

> PeptideScanner retained ClinicalTrials.gov record NCT03373435 at 2026-11-16T01:46:44.871Z. Its registry update date was 2022-07-18, and PeptideScanner's reviewed identity mapping was avexitide.

- Evidence object: `story:clinicaltrials-gov-nct03373435-avexitide:v1`
- Evidence domain: Clinical trials
- Date in source: 2022-07-18
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct03373435-avexitide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/avexitide.json#clinicaltrials-gov-nct03373435-avexitide-v1
- Content SHA-256: `f789258b3e7aba09fabae751a029082f747cfdc6161469b16776c80376987a8b`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT03373435 ([`ctg-observation-nct03373435-2022-07-18-9d51eeca0c43`](#source-ctg-observation-nct03373435-2022-07-18-9d51eeca0c43))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT03373435 at 2026-11-16T01:46:44.871Z. Its registry update date was 2022-07-18, and PeptideScanner's reviewed identity mapping was avexitide. ([`ctg-observation-nct03373435-2022-07-18-9d51eeca0c43`](#source-ctg-observation-nct03373435-2022-07-18-9d51eeca0c43))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT03373435 at 2026-11-16T01:46:44.871Z. Its registry update date was 2022-07-18, and PeptideScanner's reviewed identity mapping was avexitide. ([`ctg-observation-nct03373435-2022-07-18-9d51eeca0c43`](#source-ctg-observation-nct03373435-2022-07-18-9d51eeca0c43))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct03373435-2022-07-18-9d51eeca0c43`](#source-ctg-observation-nct03373435-2022-07-18-9d51eeca0c43))

### Sources

<a id="source-ctg-observation-nct03373435-2022-07-18-9d51eeca0c43"></a>
- **ClinicalTrials.gov record NCT03373435 · retained source version 2022-07-18:9d51eeca0c4374ca2375e19de4368370e58abd881c8ecc85ea87eba68eb09544** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT03373435) (`ctg-observation-nct03373435-2022-07-18-9d51eeca0c43`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT03373435." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/avexitide.json#clinicaltrials-gov-nct03373435-avexitide-v1 SHA-256: f789258b3e7aba09fabae751a029082f747cfdc6161469b16776c80376987a8b.

---

<a id="clinicaltrials-gov-nct04652479-avexitide-v1"></a>

## ClinicalTrials.gov record NCT04652479

> PeptideScanner retained ClinicalTrials.gov record NCT04652479 at 2026-11-16T01:46:44.871Z. Its registry update date was 2023-06-09, and PeptideScanner's reviewed identity mapping was avexitide.

- Evidence object: `story:clinicaltrials-gov-nct04652479-avexitide:v1`
- Evidence domain: Clinical trials
- Date in source: 2023-06-09
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct04652479-avexitide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/avexitide.json#clinicaltrials-gov-nct04652479-avexitide-v1
- Content SHA-256: `a75f157b9fbd605598908923d3a4f1a810c70d958f76f982b5aaf59ea9d47b21`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT04652479 ([`ctg-observation-nct04652479-2023-06-09-83505e435e43`](#source-ctg-observation-nct04652479-2023-06-09-83505e435e43))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT04652479 at 2026-11-16T01:46:44.871Z. Its registry update date was 2023-06-09, and PeptideScanner's reviewed identity mapping was avexitide. ([`ctg-observation-nct04652479-2023-06-09-83505e435e43`](#source-ctg-observation-nct04652479-2023-06-09-83505e435e43))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT04652479 at 2026-11-16T01:46:44.871Z. Its registry update date was 2023-06-09, and PeptideScanner's reviewed identity mapping was avexitide. ([`ctg-observation-nct04652479-2023-06-09-83505e435e43`](#source-ctg-observation-nct04652479-2023-06-09-83505e435e43))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct04652479-2023-06-09-83505e435e43`](#source-ctg-observation-nct04652479-2023-06-09-83505e435e43))

### Sources

<a id="source-ctg-observation-nct04652479-2023-06-09-83505e435e43"></a>
- **ClinicalTrials.gov record NCT04652479 · retained source version 2023-06-09:83505e435e435e82066de5d51c076ed06d18685c9afe866933da12a99dd2f9d6** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT04652479) (`ctg-observation-nct04652479-2023-06-09-83505e435e43`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT04652479." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/avexitide.json#clinicaltrials-gov-nct04652479-avexitide-v1 SHA-256: a75f157b9fbd605598908923d3a4f1a810c70d958f76f982b5aaf59ea9d47b21.

---

<a id="clinicaltrials-gov-nct06747468-avexitide-v1"></a>

## ClinicalTrials.gov record NCT06747468

> PeptideScanner retained ClinicalTrials.gov record NCT06747468 at 2026-11-16T01:46:44.871Z. Its registry update date was 2026-08-24, and PeptideScanner's reviewed identity mapping was avexitide.

- Evidence object: `story:clinicaltrials-gov-nct06747468-avexitide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-08-24
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct06747468-avexitide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/avexitide.json#clinicaltrials-gov-nct06747468-avexitide-v1
- Content SHA-256: `1655f12606b12b9a0edb9b404eb7cc62974615dae8b618e30628043bd24ba7b6`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT06747468 ([`ctg-observation-nct06747468-2026-08-24-84cd79c4a61d`](#source-ctg-observation-nct06747468-2026-08-24-84cd79c4a61d))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT06747468 at 2026-11-16T01:46:44.871Z. Its registry update date was 2026-08-24, and PeptideScanner's reviewed identity mapping was avexitide. ([`ctg-observation-nct06747468-2026-08-24-84cd79c4a61d`](#source-ctg-observation-nct06747468-2026-08-24-84cd79c4a61d))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT06747468 at 2026-11-16T01:46:44.871Z. Its registry update date was 2026-08-24, and PeptideScanner's reviewed identity mapping was avexitide. ([`ctg-observation-nct06747468-2026-08-24-84cd79c4a61d`](#source-ctg-observation-nct06747468-2026-08-24-84cd79c4a61d))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct06747468-2026-08-24-84cd79c4a61d`](#source-ctg-observation-nct06747468-2026-08-24-84cd79c4a61d))

### Sources

<a id="source-ctg-observation-nct06747468-2026-08-24-84cd79c4a61d"></a>
- **ClinicalTrials.gov record NCT06747468 · retained source version 2026-08-24:84cd79c4a61d08699f69791888aadfddd291dd460e6607eabfdf1782cd3756f1** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT06747468) (`ctg-observation-nct06747468-2026-08-24-84cd79c4a61d`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT06747468." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/avexitide.json#clinicaltrials-gov-nct06747468-avexitide-v1 SHA-256: 1655f12606b12b9a0edb9b404eb7cc62974615dae8b618e30628043bd24ba7b6.

